Physician profile
Charles Fulp
NPI 1669451316
$1,940.82
in general payments reported to CMS, 2019-2025
22 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $539 · 2020: $119 · 2021: $353 · 2022: $222 · 2023: $457 · 2024: $127 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $708.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trisalus Life Sciences, INC. | $523.71 | 2022-2025 | Trinav Infusion System |
| Sirtex Medical INC | $307.31 | 2019-2025 | Sir-Spheres Microspheres |
| Astrazeneca Pharmaceuticals LP | $169.84 | 2019-2021 | |
| Exelixis INC. | $125.00 | 2021 | |
| Siemens Medical Solutions USA, INC. | $121.12 | 2019-2025 | Somatom X.Cite, Artis Icono Biplane, Varian Cryocare Touch System |
| Eisai INC. | $101.39 | 2019 | |
| Galvanize Therapeutics, INC | $78.47 | 2023 | Aliya System |
| Bayer Healthcare Pharmaceuticals INC. | $72.03 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $65.11 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $62.21 | 2019-2020 | |
| Amgen INC. | $48.51 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $45.00 | 2019-2021 | |
| Instylla, INC. | $33.40 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $31.21 | 2019-2020 | |
| Angiodynamics, INC. | $31.09 | 2020-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $29.87 | 2019-2020 | |
| Acacia Pharma INC | $25.35 | 2022 | |
| Ethicon US, LLC | $16.49 | 2020 | |
| Novocure INC. | $14.37 | 2019 | |
| Lilly USA, LLC | $14.11 | 2019 | |
| Becton, Dickinson and Company | $14.01 | 2023 | M.R.I. Implantable Port |
| E.R. Squibb & Sons, L.L.C. | $11.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Fulp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.